Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runhong Zhou

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2025
BRD9 functions as an HIV-1 latency regulatory factorTsz-Yat Luk, Lok-Yan Yim, Runhong Zhou, et al.
The Lancet Regional Health. Western Pacific|January 2, 2023
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongRunhong Zhou, Na Liu, Xin Li, et al.
Ebiomedicine|November 19, 2023
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized miceYufei Mo, Ming Yue, Lok Yan Yim, et al.
Nature Communications|June 29, 2026
Sialic acid-anchored haemagglutinin stalk neutralizing antibody M-SiaB enhances protection against highly pathogenic influenza H5N1/Texas/2024Ruina Jin, Runhong Zhou, Aruzhan Aldungarova, et al.
Emerging Microbes & Infections|November 10, 2022
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2Mengxiao Luo, Biao Zhou, Eswar R Reddem, et al.
Cancer Research|October 1, 2024
A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung MetastasisHaoran Xu, Ming Yue, Runhong Zhou, et al.
Ebiomedicine|September 28, 2024
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variantsMengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
Nature Communications|April 12, 2023
An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamstersShaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, et al.
Cellular & Molecular Immunology|March 30, 2022
Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animalsZi-Wei Ye, Chon Phin Ong, Kaiming Tang, et al.
Emerging Microbes & Infections|July 4, 2020
High neutralizing antibody titer in intensive care unit patients with COVID-19Li Liu, Kelvin Kai-Wang To, Kwok-Hung Chan, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2025
BRD9 functions as an HIV-1 latency regulatory factorTsz-Yat Luk, Lok-Yan Yim, Runhong Zhou, et al.
The Lancet Regional Health. Western Pacific|January 2, 2023
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongRunhong Zhou, Na Liu, Xin Li, et al.
Ebiomedicine|November 19, 2023
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized miceYufei Mo, Ming Yue, Lok Yan Yim, et al.
Nature Communications|June 29, 2026
Sialic acid-anchored haemagglutinin stalk neutralizing antibody M-SiaB enhances protection against highly pathogenic influenza H5N1/Texas/2024Ruina Jin, Runhong Zhou, Aruzhan Aldungarova, et al.
Emerging Microbes & Infections|November 10, 2022
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2Mengxiao Luo, Biao Zhou, Eswar R Reddem, et al.
Cancer Research|October 1, 2024
A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung MetastasisHaoran Xu, Ming Yue, Runhong Zhou, et al.
Ebiomedicine|September 28, 2024
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variantsMengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
Nature Communications|April 12, 2023
An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamstersShaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, et al.
Cellular & Molecular Immunology|March 30, 2022
Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animalsZi-Wei Ye, Chon Phin Ong, Kaiming Tang, et al.
Emerging Microbes & Infections|July 4, 2020
High neutralizing antibody titer in intensive care unit patients with COVID-19Li Liu, Kelvin Kai-Wang To, Kwok-Hung Chan, et al.
Pageof 5